针对性治疗可以改善BMD iPSC肌源性细胞移植和dystrophin表达in vivo
Muchen Liu1,2, Somik Chatterjee1,2, Jianbo Wu3
1Institute of Muscle Biology and Cachexia (IMBC), University of Houston, Houston, TX, USA.
Molecular therapy. Methods & clinical development
|July 18, 2025
概括
针对全方位化途径的新疗法对贝克尔肌肉发育不良症 (BMD) 显示出前景. 抑制剂在临床前研究中改善了肌肉细胞存活率和营养不良蛋白水平,为这种渐进性肌肉衰弱疾病的患者提供了希望.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 贝克尔肌肉发育不良症 (BMD) 源于内框架基因突变,导致渐进的肌肉衰弱和器官并发症.
- 双氨酸的稳定性由多-ubiquitination 调节,由 lncRNA H19 与双氨酸 C-终端指域 (ZNF) 结合的抑制.
- BMD突变破坏了ZNF构造,减少了H19结合,并增加了素无处不在.
研究的目的:
- 为了研究BMD诱导的多能干细胞 (iPSC) 衍生的肌源性细胞的肌源性潜力.
- 评估新型分子的治疗疗效,这些新型分子向肌肉骨干疾病中的基基化途径.
主要方法:
- 使用BMD iPSCs来评估*in vitro*肌原细胞分化和功能.
- 进行了"体外"和"体内"的研究,以测试候选治疗分子.
- 在动物模型中使用TRIM63和α-synuclein聚合抑制剂.
主要成果:
- BMD iPSC 衍生的神经细胞表现出差异化,增殖,亡和衰老的增加 *in vitro*.
- *体内*研究显示,在用两种候选分子治疗的BMD iPSC肌细胞中,生存率和肌蛋白表达得到改善.
- TRIM63和α-synuclein聚合抑制剂表明了治疗潜力.
结论:
- 在BMD肌源性细胞的缺陷突出显示疾病的细胞影响.
- 用特定的抑制剂准无处不在的途径为BMD提供了一个有前途的治疗策略.
- 进一步开发这些抑制剂可以改善肌肉前体细胞存活率和骨质疏松症患者的双素水平.
相关概念视频
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K